Showing results (301-310 of 673) with videos related to

Sort By:
Pageof 68
HIV Clinical Trials|December 1, 2014
Discontinuation of tenofovir disoproxil fumarate for presumed renal adverse events in treatment-naïve HIV-1 patients: meta-analysis of randomized clinical studiesJonathan Winston, Michel Chonchol, Joel Gallant, et al.
HIV Clinical Trials|December 1, 2014
Cobicistat-boosted protease inhibitors in HIV-infected patients with mild to moderate renal impairmentCheryl K McDonald, Claudia Martorell, Moti Ramgopal, et al.
HIV Clinical Trials|April 30, 2016
Fosamprenavir/ritonavir in patients with viral hepatitis coinfection: an observational multicohort studyPaola Nasta, Dominique Salmon, Antonella d'Arminio Monforte, et al.
HIV Clinical Trials|April 30, 2016
Non-classical monocytes predict progression of carotid artery bifurcation intima-media thickness in HIV-infected individuals on stable antiretroviral therapyDominic C Chow, Jamie M Kagihara, Guangxiang Zhang, et al.
HIV Clinical Trials|April 30, 2016
A cross-sectional study to evaluate the association of hyperbilirubinaemia on markers of cardiovascular disease, neurocognitive function, bone mineral density and renal markers in HIV-1 infected subjects on protease inhibitorsT J Barber, G Moyle, A Hill, et al.
HIV Clinical Trials|January 6, 2016
Measuring the potential role of frailty in apparent declining efficacy of HIV interventionsFelicia P Hardnett, Charles E Rose
HIV Clinical Trials|January 8, 2016
Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative ColitisZuleika Michelini, Silvia Baroncelli, Alessandra Fantauzzi, et al.
HIV Clinical Trials|May 13, 2016
The Framingham function overestimates the risk of ischemic heart disease in HIV-infected patients from BarcelonaSabina Herrera, Ana Guelar, Luisa Sorlì, et al.
HIV Clinical Trials|May 18, 2018
The effect of switching protease inhibitors to raltegravir on endothelial function, in HIV-infected patientsMaaike Krikke, Kiki Tesselaar, Guido E L van den Berk, et al.
HIV Clinical Trials|May 18, 2018
Rosuvastatin and atorvastatin preserve renal function in HIV-1-infected patients with chronic kidney disease and hyperlipidaemiaLeonardo Calza, Vincenzo Colangeli, Marco Borderi, et al.
Pageof 68